Amyloid-like oligomerization of AIMP2 contributes to α-synuclein interaction and Lewy-like inclusion
- 11 November 2020
- journal article
- research article
- Published by American Association for the Advancement of Science (AAAS) in Science Translational Medicine
- Vol. 12 (569)
Abstract
Pathological AIMP2 aggregation leads to α-synuclein inclusion and dopaminergic toxicity in Parkinson’s disease.Keywords
Funding Information
- National Institute of Neurological Disorders and Stroke (NS38377; NS107404; NS098006)
- National Institute of Neurological Disorders and Stroke (NS072026)
- National Research Foundation of Korea (2017M3C7A1043848)
This publication has 61 references indexed in Scilit:
- Pathological α-Synuclein Transmission Initiates Parkinson-like Neurodegeneration in Nontransgenic MiceScience, 2012
- -Synuclein in Parkinson's DiseaseCold Spring Harbor Perspectives in Medicine, 2011
- Interactions of Pathological Hallmark ProteinsJournal of Biological Chemistry, 2011
- Induction of Intracellular Tau Aggregation Is Promoted by α-Synuclein Seeds and Provides Novel Insights into the Hyperphosphorylation of TauJournal of Neuroscience, 2011
- PARIS (ZNF746) Repression of PGC-1α Contributes to Neurodegeneration in Parkinson's DiseaseCell, 2011
- Novel Regulation of Parkin Function through c-Abl-Mediated Tyrosine Phosphorylation: Implications for Parkinson's DiseaseThe Journal of Neuroscience, 2011
- Phosphorylation by the c-Abl protein tyrosine kinase inhibits parkin's ubiquitination and protective functionProceedings of the National Academy of Sciences of the United States of America, 2010
- Genetic Animal Models of Parkinson's DiseaseNeuron, 2010
- AIMP2/p38, the scaffold for the multi-tRNA synthetase complex, responds to genotoxic stresses via p53Proceedings of the National Academy of Sciences, 2008
- Autophagy-mediated clearance of aggresomes is not a universal phenomenonHuman Molecular Genetics, 2008